CO5611156A2 - Metodos de tratamiento de enfermedad vascular - Google Patents
Metodos de tratamiento de enfermedad vascularInfo
- Publication number
- CO5611156A2 CO5611156A2 CO04084713A CO04084713A CO5611156A2 CO 5611156 A2 CO5611156 A2 CO 5611156A2 CO 04084713 A CO04084713 A CO 04084713A CO 04084713 A CO04084713 A CO 04084713A CO 5611156 A2 CO5611156 A2 CO 5611156A2
- Authority
- CO
- Colombia
- Prior art keywords
- angioplasty
- patient
- treatment methods
- vascular disease
- disease treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Laser Surgery Devices (AREA)
Abstract
1.- Un método para desarrollar angioplastia en un paciente, el método comprende:(a) Desarrollar la angioplastia en el paciente; y(b) Antes, durante, o después (a), administrar al paciente un composición farmacéutica que comprende una cantidad de monóxido de carbono para tratar la hiperplasia íntima en el paciente.2.- El método de la reivindicación 1, en donde la angioplastia comprende angioplastia de globo.3.- El método de la reivindicación 1, en donde la angioplastia comprende angioplastia láser.4.- El método de la reivindicación 1, en donde la angioplastia comprende aterectomía direccional.5.- El método de la reivindicación 1, en donde la angioplastia comprende aterectomía rotacional.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35671802P | 2002-02-13 | 2002-02-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5611156A2 true CO5611156A2 (es) | 2006-02-28 |
Family
ID=27765943
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO04084713A CO5611156A2 (es) | 2002-02-13 | 2004-08-30 | Metodos de tratamiento de enfermedad vascular |
Country Status (15)
Country | Link |
---|---|
US (2) | US7364757B2 (es) |
EP (1) | EP1480658B1 (es) |
JP (1) | JP2005525848A (es) |
KR (1) | KR20040096571A (es) |
CN (1) | CN100393323C (es) |
AU (1) | AU2003211102B2 (es) |
BR (1) | BRPI0307673A2 (es) |
CA (1) | CA2475963A1 (es) |
CO (1) | CO5611156A2 (es) |
EA (1) | EA200401070A1 (es) |
MX (1) | MXPA04007896A (es) |
NO (1) | NO20034590L (es) |
SG (1) | SG148850A1 (es) |
UA (1) | UA86344C2 (es) |
WO (1) | WO2003072024A2 (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7678390B2 (en) * | 1999-04-01 | 2010-03-16 | Yale University | Carbon monoxide as a biomarker and therapeutic agent |
GB0111872D0 (en) | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
WO2003000114A2 (en) * | 2001-06-21 | 2003-01-03 | Beth Israel Deaconess Medical Center | Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
US7011854B2 (en) * | 2002-02-04 | 2006-03-14 | Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda | Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
US7968605B2 (en) * | 2002-02-04 | 2011-06-28 | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
US20080026984A1 (en) * | 2002-02-04 | 2008-01-31 | Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
AU2003211102B2 (en) * | 2002-02-13 | 2010-03-04 | Beth Israel Deaconess Medical Center, Inc. | Methods of treating vascular disease |
RS91004A (en) | 2002-04-15 | 2007-02-05 | University Of Pittsburgh Of The Commonwealth System Of Higher Education, | Methods of treating ileus |
CA2481786A1 (en) * | 2002-04-15 | 2003-10-30 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Methods of treating necrotizing enterocolitis |
US8097585B2 (en) | 2002-04-15 | 2012-01-17 | Beth Israel Deaconess Medical Center, Inc. | Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation |
WO2003096977A2 (en) * | 2002-05-17 | 2003-11-27 | Yale University | Methods of treating hepatitis |
EA200401622A1 (ru) * | 2002-06-05 | 2005-06-30 | Йейл Юниверсити | Способы лечения ангиогенеза, роста опухолей и метастазов |
US20040131703A1 (en) * | 2002-06-21 | 2004-07-08 | Bach Fritz H. | Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
JP2006514621A (ja) * | 2002-11-07 | 2006-05-11 | ユニバーシティー オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション | 出血性ショックの治療 |
GB2395432B (en) * | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
US20040236279A1 (en) * | 2003-05-22 | 2004-11-25 | Atrium Medical Corp. | Gaseous therapeutic agent delivery |
EP1684580A2 (en) * | 2003-10-22 | 2006-08-02 | Fred Hutchinson Cancer Research Center | Methods, compositions and devices for inducing stasis in tissues and organs |
WO2006024489A2 (en) * | 2004-08-30 | 2006-03-09 | Interstitial Therapeutics | Methods and compositions for the treatment of cell proliferation |
US7523752B2 (en) | 2005-09-21 | 2009-04-28 | Ino Therapeutics, Llc | System and method of administering a pharmaceutical gas to a patient |
US8893717B2 (en) | 2005-09-21 | 2014-11-25 | Ino Therapeutics Llc | Systems and methods of administering a pharmaceutical gas to a patient |
WO2007073226A1 (en) * | 2005-12-20 | 2007-06-28 | Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda | Method for treating a mammal by administration of a compound having the ability to release co |
GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
WO2008080128A1 (en) * | 2006-12-22 | 2008-07-03 | The Board Of Regents Of The University Of Texas System | Devices and methods for inhibiting fibrosis |
DK3210644T3 (en) | 2009-05-27 | 2019-02-04 | Ino Therapeutics Llc | DEVICES FOR CONNECTING INDEXED VALVE AND PRESSURE CONTAINER WITH REQUIREMENTS |
CA2671029A1 (en) | 2009-06-30 | 2010-12-30 | James S. Baldassarre | Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension |
HUP1000243A2 (en) | 2010-05-06 | 2012-01-30 | Avidin Kft | 8-hidroxy-quinoline derivatives |
US8778413B2 (en) * | 2010-05-14 | 2014-07-15 | Ikaria, Inc. | Dosing regimens and methods of treatment using carbon monoxide |
CN103491783A (zh) * | 2011-01-14 | 2014-01-01 | 洛杉矶儿童医院 | 用于治疗包括镰状细胞疾病的疾病的一氧化碳溶液 |
WO2012145520A2 (en) | 2011-04-19 | 2012-10-26 | Alfama, Inc. | Carbon monoxide releasing molecules and uses thereof |
WO2013013179A1 (en) | 2011-07-21 | 2013-01-24 | Alfama, Inc. | Ruthenium carbon monoxide releasing molecules and uses thereof |
JP2014525399A (ja) * | 2011-08-09 | 2014-09-29 | ベス・イスラエル・ディーコネス・メディカル・センター,インコーポレイテッド | Dna損傷を処置する方法 |
CA2867022C (en) | 2012-03-15 | 2020-12-15 | Ino Therapeutics Llc | Methods of administering high concentrations of nitric oxide |
US20140272924A1 (en) * | 2013-03-14 | 2014-09-18 | Ganogen, Inc. | Transplantation and growth of human fetal organs in non-human animal hosts |
TW201618795A (zh) | 2014-04-15 | 2016-06-01 | 波泰里斯股份有限公司 | 用以改良器官功能及延長器官移植物壽命之系統及方法 |
JP6591203B2 (ja) * | 2015-06-01 | 2019-10-16 | キヤノンメディカルシステムズ株式会社 | 医用画像処理装置 |
CN113289074A (zh) * | 2020-02-24 | 2021-08-24 | 张建强 | 一种新型的药物涂层支架及其制备方法 |
EP4210732A1 (en) * | 2020-09-08 | 2023-07-19 | The Brigham & Women's Hospital, Inc. | Therapeutic carbon monoxide formulations |
Family Cites Families (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4053590A (en) * | 1975-02-27 | 1977-10-11 | Alza Corporation | Compositions of matter comprising macromolecular hemoglobin |
US4264739A (en) * | 1979-01-05 | 1981-04-28 | Merck & Co., Inc. | Sparger for cell culture system |
JPS5679957A (en) | 1979-12-05 | 1981-06-30 | Sogo Seibutsu Igaku Kenkyusho:Kk | Erucinia enterocolitica polysaccharide sensitizing blood cell and method of detecting erucinia enterocolitica polysaccharide antibody using this |
US5240912A (en) * | 1983-05-09 | 1993-08-31 | Todaro George J | Transforming growth factor (TGF) peptides |
US4979939A (en) * | 1984-05-14 | 1990-12-25 | Surgical Systems & Instruments, Inc. | Atherectomy system with a guide wire |
US5084380A (en) * | 1985-01-29 | 1992-01-28 | Applied Biotechnology | Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins |
US5449665A (en) * | 1985-09-24 | 1995-09-12 | Item Development Aktiebolag | Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty |
DE3739650C1 (de) * | 1987-11-23 | 1989-05-24 | Immuno Ag | Fermenter zum Zuechten von Zellkulturen |
US5674192A (en) | 1990-12-28 | 1997-10-07 | Boston Scientific Corporation | Drug delivery |
US5180366A (en) * | 1990-10-10 | 1993-01-19 | Woods W T | Apparatus and method for angioplasty and for preventing re-stenosis |
US5792325A (en) * | 1990-11-15 | 1998-08-11 | Richardson, Jr.; William H. | Electric arc material processing system |
GB9124195D0 (en) * | 1991-11-14 | 1992-01-08 | Boc Group Plc | Connection to a gas cylinder |
US5293875A (en) * | 1992-06-16 | 1994-03-15 | Natus Medical Incorporated | In-vivo measurement of end-tidal carbon monoxide concentration apparatus and methods |
EP0693924B2 (en) * | 1993-02-22 | 2008-04-09 | Abraxis BioScience, Inc. | Methods for (in vivo) delivery of biologics and compositions useful therefor |
AU6523194A (en) | 1993-03-26 | 1994-10-24 | Biorelease Technologies, Inc. | Compositions including heme-containing proteins and methods relating thereto |
US5523092A (en) * | 1993-04-14 | 1996-06-04 | Emory University | Device for local drug delivery and methods for using the same |
US5985307A (en) * | 1993-04-14 | 1999-11-16 | Emory University | Device and method for non-occlusive localized drug delivery |
US5763431A (en) * | 1993-08-20 | 1998-06-09 | Jackson; Meyer B. | Method for regulating neuropeptide hormone secretion |
US5588962A (en) * | 1994-03-29 | 1996-12-31 | Boston Scientific Corporation | Drug treatment of diseased sites deep within the body |
DE4421433C1 (de) | 1994-06-18 | 1995-06-08 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Wirkstoffen, die Kohlenmonoxid-Quellen darstellen, Verfahren zu seiner Herstellung und seine Verwendung |
US5476764A (en) * | 1994-09-16 | 1995-12-19 | The Regents Of The University Of California | Method using CO for extending the useful shelf-life of refrigerated red blood cells |
US6066333A (en) * | 1994-09-22 | 2000-05-23 | William Harvey Research Limited | Pharmaceutical control of inflammation |
JPH0898893A (ja) * | 1994-09-29 | 1996-04-16 | Terumo Corp | 薬剤投与カテーテル |
US5664563A (en) * | 1994-12-09 | 1997-09-09 | Cardiopulmonary Corporation | Pneumatic system |
US5914316A (en) * | 1994-12-16 | 1999-06-22 | Washington University | Method of inhibiting intimal hyperplasia |
US5712293A (en) * | 1995-06-07 | 1998-01-27 | Sepracor, Inc. | Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride |
JP3019366U (ja) * | 1995-06-13 | 1995-12-12 | 株式会社大東バルブ製作所 | 特定ガス用ボンベ |
FR2735382B1 (fr) * | 1995-06-15 | 1997-07-25 | Air Liquide | Installation de production de monoxyde de carbone incorporant une unite de separation cryogenique |
JP3195363B2 (ja) * | 1995-06-30 | 2001-08-06 | ザイモジェネティクス,インコーポレイティド | Pdgfアンタゴニストとしての4−〔2−(n−2−カルボキサミドインドール)アミノエチル〕ベンゼンスルホンアミドまたはスルホニル尿素 |
DE19535781C2 (de) * | 1995-09-26 | 1999-11-11 | Fraunhofer Ges Forschung | Vorrichtung zur aktiven Strömungsunterstützung von Körperflüssigkeiten |
CN1208053C (zh) * | 1996-04-05 | 2005-06-29 | 综合医院公司 | 气体氧化氮在制备用于治疗血红蛋白病的冶疗气体中的应用 |
US6069132A (en) * | 1996-08-14 | 2000-05-30 | Revanker; Ganapathi R. | Phosphazole compounds |
CA2264182A1 (en) * | 1996-08-23 | 1998-02-26 | Algos Pharmaceutical Corporation | Anticonvulsant containing composition for treating neuropathic pain |
PT921807E (pt) * | 1996-08-27 | 2004-04-30 | Messer Griesheim Gmbh | Medicamentos contendo hidrogenio |
US6316403B1 (en) * | 1996-09-27 | 2001-11-13 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
US6315995B1 (en) | 1996-09-27 | 2001-11-13 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
US8128963B2 (en) * | 1996-09-27 | 2012-03-06 | The Trustees Of Columbia University In The City Of New York | Methods for treating ischemic disorders using carbon monoxide |
JP2001501612A (ja) * | 1996-09-27 | 2001-02-06 | ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク | 虚血性疾患を治療する方法及び発作後の症状を改善する方法 |
US6436365B2 (en) * | 1997-09-23 | 2002-08-20 | Schering Aktiengesellschaft | Process for therapeutic treatment of proliferative diseases |
US6251418B1 (en) * | 1997-12-18 | 2001-06-26 | C.R. Bard, Inc. | Systems and methods for local delivery of an agent |
TR200101501T2 (tr) | 1998-03-16 | 2002-06-21 | Celgene Corporation | 2-(2,6-dioksopiperidin-3-il)izoindolin türevleri, bunların hazırlanması ve enflamatuar sitokinlerin inhibitörleri olarak kullanımı. |
US6450989B2 (en) * | 1998-04-27 | 2002-09-17 | Artemis Medical, Inc. | Dilating and support apparatus with disease inhibitors and methods for use |
JP4023919B2 (ja) * | 1998-07-21 | 2007-12-19 | 株式会社フクダ産業 | 肺機能検査装置 |
US6203991B1 (en) * | 1998-08-21 | 2001-03-20 | The Regents Of The University Of Michigan | Inhibition of smooth muscle cell migration by heme oxygenase I |
US20050250688A1 (en) * | 1999-04-01 | 2005-11-10 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
DE19932824A1 (de) * | 1999-07-14 | 2001-03-08 | Nordischer Maschinenbau | Verfahren und Vorrichtung zum Ausrichten eines toten Fisches |
JP2001082698A (ja) * | 1999-09-16 | 2001-03-30 | Teijin Ltd | 医療用酸素ボンベ |
US7632803B2 (en) * | 1999-10-01 | 2009-12-15 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
US6508784B1 (en) * | 2000-05-19 | 2003-01-21 | Yan-Ho Shu | Balloon catheter having adjustable centering capabilities and methods thereof |
FR2812197B1 (fr) | 2000-07-27 | 2003-01-03 | Air Liquide Sante Int | Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches |
FR2816212A1 (fr) * | 2000-11-03 | 2002-05-10 | Air Liquide Sante Int | Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire |
BR0208012A (pt) * | 2001-03-20 | 2004-03-02 | Glaxo Group Ltd | Usos de pelo menos duas drogas e um propelente hfa e de pelo menos uma composição farmaceêutica, e, inalador acondicionado para tratar asma |
IL158182A0 (en) * | 2001-03-30 | 2004-03-28 | Sangstat Medical Corp | Carbon monoxide generating compounds for treatment of vacular, inflammatory and immune disorders |
GB0111872D0 (en) | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
EP1395241B9 (en) * | 2001-05-25 | 2005-06-15 | Medtronic, Inc. | Implantable medical device with controllable gaseous agent release system |
WO2003000114A2 (en) | 2001-06-21 | 2003-01-03 | Beth Israel Deaconess Medical Center | Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
US7011854B2 (en) * | 2002-02-04 | 2006-03-14 | Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda | Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
AU2003211102B2 (en) * | 2002-02-13 | 2010-03-04 | Beth Israel Deaconess Medical Center, Inc. | Methods of treating vascular disease |
US8097585B2 (en) * | 2002-04-15 | 2012-01-17 | Beth Israel Deaconess Medical Center, Inc. | Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation |
DE10230165A1 (de) | 2002-07-04 | 2004-01-15 | Ino Therapeutics Gmbh | Verfahren und Vorrichtung zur Administration von Kohlenmonoxid |
-
2003
- 2003-02-13 AU AU2003211102A patent/AU2003211102B2/en not_active Ceased
- 2003-02-13 CN CNB038083523A patent/CN100393323C/zh not_active Expired - Fee Related
- 2003-02-13 UA UA20040907416A patent/UA86344C2/ru unknown
- 2003-02-13 KR KR10-2004-7012581A patent/KR20040096571A/ko not_active Application Discontinuation
- 2003-02-13 MX MXPA04007896A patent/MXPA04007896A/es active IP Right Grant
- 2003-02-13 WO PCT/US2003/004665 patent/WO2003072024A2/en active Application Filing
- 2003-02-13 JP JP2003570771A patent/JP2005525848A/ja active Pending
- 2003-02-13 CA CA002475963A patent/CA2475963A1/en not_active Abandoned
- 2003-02-13 US US10/367,277 patent/US7364757B2/en not_active Expired - Lifetime
- 2003-02-13 EA EA200401070A patent/EA200401070A1/ru unknown
- 2003-02-13 BR BRPI0307673A patent/BRPI0307673A2/pt not_active IP Right Cessation
- 2003-02-13 SG SG200605472-0A patent/SG148850A1/en unknown
- 2003-02-13 EP EP03743140.0A patent/EP1480658B1/en not_active Expired - Lifetime
- 2003-10-13 NO NO20034590A patent/NO20034590L/no not_active Application Discontinuation
-
2004
- 2004-08-30 CO CO04084713A patent/CO5611156A2/es not_active Application Discontinuation
-
2008
- 2008-03-18 US US12/050,826 patent/US7691416B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
BRPI0307673A2 (pt) | 2016-11-08 |
CN1646146A (zh) | 2005-07-27 |
JP2005525848A (ja) | 2005-09-02 |
NO20034590D0 (no) | 2003-10-13 |
MXPA04007896A (es) | 2005-06-17 |
US7364757B2 (en) | 2008-04-29 |
CA2475963A1 (en) | 2003-09-04 |
US20080167609A1 (en) | 2008-07-10 |
WO2003072024A3 (en) | 2004-02-26 |
EP1480658B1 (en) | 2017-01-25 |
EP1480658A2 (en) | 2004-12-01 |
US20030219496A1 (en) | 2003-11-27 |
AU2003211102A1 (en) | 2003-09-09 |
US7691416B2 (en) | 2010-04-06 |
CN100393323C (zh) | 2008-06-11 |
KR20040096571A (ko) | 2004-11-16 |
EP1480658A4 (en) | 2005-03-16 |
UA86344C2 (ru) | 2009-04-27 |
SG148850A1 (en) | 2009-01-29 |
WO2003072024A2 (en) | 2003-09-04 |
NO20034590L (no) | 2003-12-12 |
EA200401070A1 (ru) | 2005-02-24 |
AU2003211102B2 (en) | 2010-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5611156A2 (es) | Metodos de tratamiento de enfermedad vascular | |
BRPI0314854B8 (pt) | cateter balão, processo para seu revestimento, e uso de uma solução. | |
ATE555782T1 (de) | Prävention und/oder behandlung von kardiovaskulären erkrankungen und/oder damit zusammenhängender herzinsuffizienz | |
BR9807816A (pt) | Permeação anestésica tópica assistida a laser | |
SE9404196D0 (sv) | New antithrombotic formulation | |
ECSP045442A (es) | "composiciones y metodo para el tratamiento de infección en ganado vacuno y porcino" | |
ES2073583T3 (es) | Dispositivo para irradiar rayos laser. | |
AR033548A1 (es) | Composicion farmaceutica que comprende un inhibidor de lipasa, un procedimiento para su preparacion, equipo transportable a modo de ''kit'', el uso de dicha composicion en la fabricacion de medicamentos, un inhibidor de lipasa y un secuestrante de acidos biliares | |
WO1994004222A3 (en) | Adjunctive photodynamic therapy for treating cardiovascular disease | |
HUP0303923A2 (hu) | Szterin abszorpció inhibitor(ok)kombinációi kardiovaszkuláris szerekkel vaszkuláris kondíciók kezelésére és a kombinációt tartalmazó készítmények | |
ATE312635T1 (de) | Ventilanordnung | |
NO20080855L (no) | Behandling med azetidinon-baserte kolesterol absorpsjonsinhibitorer og omega-3 fettsyrer og et kombinasjonsprodukt derav | |
PT1163904E (pt) | Composicao para a prevencao de doencas do musculo liso, compreendendo ascorbato, arginina e magnesio | |
MXPA04004170A (es) | Tratamiento del sindrome de resitencia a la insulina y diabetes de tipo 2 con inhibidores de pde9. | |
AR026610A1 (es) | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central | |
CO5670327A2 (es) | Procedimiento para el tratamiento de trastornos de depresion y ansiedad mediante terapia de combinacion | |
EA200401525A1 (ru) | Способы лечения гепатита (варианты ) | |
HUP0303917A2 (hu) | Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére | |
PT91863A (pt) | Processo de preparacao de uma preparacao farmaceutica a base de gama-interferao | |
CO5590913A2 (es) | Terapia de combinacion antivirica | |
WO2002000210A3 (en) | Use of agents capable of reducing uric acid levels for the treatment of cardiovascular disease | |
WO2005055956A3 (en) | Method for improving insulin sensitivity by administering an inhibitor of antitrypsin | |
WO2008016378A3 (en) | Methods to treat and/or prevent radiation- and/or chemical-induced toxicity in non-malignant tissue | |
DK1581239T3 (da) | Tidlig anvendelse af et ekstrakt af røde vinblade | |
MD2872G2 (ro) | Metodă de pronostic al riscului apariţiei hiperplaziei dishormonale a glandei mamare |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |